DBS Leadwire Stimulation Control and Volume of Activation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current deep brain stimulation (DBS) technologies face challenges in predicting the volume of tissue influenced by stimulation due to the complex, anisotropic characteristics of the 3D tissue medium near the electrode, leading to undesirable side effects and limited understanding of neural response.

Innovation Solution

A system and method that quantify the degree of overlap between the estimated volume of activation (VOA) and a target volume, using metrics like the Jaccard index and Rand index, and display graphical user interfaces to visualize and adjust stimulation parameters, allowing for better control and optimization of stimulation leadwires in relation to anatomical regions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If electrical stimulation is applied to treat neurological disorders, then therapeutic efficacy is improved, but side effects increase due to unpredictable volume of activation

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system employs feedback by calculating the overlap between estimated volume of activation (VOA) and target volume, then using this overlap information to adjust stimulation parameters. The processor continuously monitors the stimulation effect and modifies parameters to maintain optimal overlap while minimizing spill into non-target regions, thereby reducing side effects while preserving therapeutic efficacy.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system changes stimulation parameters (amplitude, pulse width, frequency) based on calculated overlap metrics. By adjusting these parameters, the system optimizes the volume of activation to match the target volume more precisely, improving therapeutic effect while reducing activation of non-target tissue that causes side effects.

Inventive Principle:
Principle #35Parameter changes

2Volume of moving object

If stimulation parameters are increased to expand volume of activation, then coverage of target region is improved, but spill into non-target regions increases causing more side effects

Engineering Contradiction:
Improvevolume of activationVSAvoidspill into non-target regions
Core Design Contradiction:
Volume of moving objectVSObject-affected harmful factors

Solution Approach 1:

The system adjusts stimulation parameters to optimize the volume of activation. By changing amplitude, pulse width, and frequency parameters, the system expands VOA coverage of the target region while maintaining control over the spatial distribution, preventing excessive spill into non-target regions.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The system uses feedback from overlap calculations to regulate parameter adjustments. When VOA begins to spill into non-target regions, the system receives feedback about the increased overlap ratio and automatically adjusts parameters to reduce spill while maintaining adequate target coverage.

Inventive Principle:
Principle #23Feedback

3Measurement precision

If complex 3D tissue characteristics are considered for accurate prediction, then measurement precision is improved, but device complexity increases

Engineering Contradiction:
Improveprediction accuracy of volume of activationVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system introduces an intermediary computational model that simplifies the complex 3D tissue characteristics into manageable parameters for VOA prediction. The processor uses this intermediary model to calculate overlap without requiring full complexity of tissue anisotropy and inhomogeneity, achieving acceptable prediction accuracy while maintaining reasonable system complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS9081488B2Stimulation leadwire and volume of activation control and display interface
Publication Date: 2015.07.14 BOSTON SCI NEUROMODULATION CORP
  • US9081488B2 patent drawing
  • US9081488B2 patent drawing
  • US9081488B2 patent drawing

AI summary

A method and system include a processor that outputs a model of anatomical structures of a region in which a leadwire is implanted, the structures being distinguished by graphical indicia associated with respective textual descriptions in a legend. Electrodes of a model of the leadwire overlaid on the anatomical structure models are selectable, in response to which selection the processor displays a control for modifying an electrical setting of the selected contact.